Gene:
ATN1
atrophin 1

PharmGKB contains no dosing guidelines for this . To report known genotype-based dosing guidelines, or if you are interested in developing guidelines, click here.

PharmGKB contains no drug labels with pharmacogenomic information for this . To report a drug label with PGx, click here.

Disclaimer: The PharmGKB's clinical annotations reflect expert consensus based on clinical evidence and peer-reviewed literature available at the time they are written and are intended only to assist clinicians in decision-making and to identify questions for further research. New evidence may have emerged since the time an annotation was submitted to the PharmGKB. The annotations are limited in scope and are not applicable to interventions or diseases that are not specifically identified.

The annotations do not account for individual variations among patients, and cannot be considered inclusive of all proper methods of care or exclusive of other treatments. It remains the responsibility of the health-care provider to determine the best course of treatment for a patient. Adherence to any guideline is voluntary, with the ultimate determination regarding its application to be made solely by the clinician and the patient. PharmGKB assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the PharmGKB clinical annotations, or for any errors or omissions.

? = Mouse-over for quick help

This is a non-comprehensive list of genetic tests with pharmacogenetics relevance, typically submitted by the manufacturer and manually curated by PharmGKB. The information listed is provided for educational purposes only and does not constitute an endorsement of any listed test or manufacturer.

A more complete listing of genetic tests is found at the Genetic Testing Registry (GTR).

PGx Test Variants Assayed Related Drugs?

Overview

Alternate Names:  None
Alternate Symbols:  B37
PharmGKB Accession Id: PA27487

Details

Cytogenetic Location: chr12 : p13.31 - p13.31
GP mRNA Boundary: chr12 : 7033626 - 7051484
GP Gene Boundary: chr12 : 7023626 - 7054484
Strand: plus
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

LinkOuts

Entrez Gene:
1822
OMIM:
125370
607462
UCSC Genome Browser:
NM_001940
RefSeq RNA:
NM_001007026
NM_001940
RefSeq Protein:
NP_001007027
NP_001931
RefSeq DNA:
AC_000055
AC_000144
NC_000012
NG_008047
NT_009759
NW_001838050
NW_925295
UniProtKB:
ATN1_HUMAN (P54259)
Q86V38_HUMAN (Q86V38)
Ensembl:
ENSG00000111676
GenAtlas:
ATN1
GeneCard:
ATN1
MutDB:
ATN1
ALFRED:
LO011051I
HuGE:
ATN1
Comparative Toxicogenomics Database:
1822
ModBase:
P54259
HumanCyc Gene:
HS03445
HGNC:
3033

Common Searches